Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Professor David Gallagher

Clinical Professor (Clinical Medicine)
ST JAMESS HOSPITAL


Details Date
National Cancer Control Programme Executive Committee 2015-present
Bobby Bastow Cancer Genetics Foundation Chair 2014-present
Reviewer for New England Journal of Medicine 2016
Reviewer for Journal of Clinical Oncology 2012-2017
Details Date From Date To
FRCPI 2010 2019
Irish Society of Medical Oncology 2010 2019
Cancer Trials Ireland 2010 2019
American Society of Clinincal Oncology 2005 2019
European Society of Medical Oncology 2010 2019
PRACTICAL: The PRostate cancer AssoCiation Group To Investigate Cancer Associated aLterations in the genome 2011 2019
COGS: The Collaborative Ovarian, prostate, and breast Gene environment Study 2011 2019
CIMBA BRCA1/2 mutation carrier consortium 2013 2019
O'Shea R, Clarke R, Berkley E, Giffney C, Farrell M, O'Donovan E, Gallagher DJ., Next generation sequencing is informing phenotype: a TP53 example., Familial cancer, 17, (1), 2018, p123-128 , Journal Article, PUBLISHED  DOI
McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ., Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series., Cancer genetics, 214-215, 2017, p1-8 , Journal Article, PUBLISHED  DOI
Saya S, Killick E, Thomas S, Taylor N, Bancroft EK, Rothwell J, Benafif S, Dias A, Mikropoulos C, Pope J, Chamberlain A, Gunapala R, SIGNIFY Study Steering Committee, Izatt L, Side L, Walker L, Tomkins S, Cook J, Barwell J, Wiles V, Limb L, Eccles D, Leach MO, Shanley S, Gilbert FJ, Hanson H, Gallagher D, Rajashanker B, Whitehouse RW, Koh DM, Sohaib SA, Evans DG, Eeles RA., Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls., Familial cancer, 16, (3), 2017, p433-440 , Journal Article, PUBLISHED  DOI
Gleeson J, Gallagher D., Diagnosing Lynch Syndrome., Irish medical journal, 109, (10), 2016, p487 , Journal Article, PUBLISHED  DOI
McVeigh TP, Duff M, Carroll C, O'Shea R, Bradley L, Farrell M, Gallagher DJ, Clabby C, Green AJ., MUTYH-Associated Polyposis: The Irish Experience>., Irish medical journal, 109, (10), 2016, p485 , Journal Article, PUBLISHED  DOI
McVeigh TP, Sweeney KJ, Kerin MJ, Gallagher DJ., A qualitative analysis of the attitudes of Irish patients towards participation in genetic-based research., Ir J Med Sci, 185, (4), 2016, p825-831 , Journal Article, PUBLISHED  DOI
Gogarty DS, Farrell MP, Gallagher DJ., Genetic testing and interpretive complexity: a BRCA1 gene mutation example., Ir J Med Sci, 185, (4), 2016, p955-957 , Journal Article, PUBLISHED  DOI
Sharma S, Barry M, Gallagher DJ, Kell M, Sacchini V., An overview of triple negative breast cancer for surgical oncologists., Surgical oncology, 24, (3), 2015, p276-283 , Journal Article, PUBLISHED  DOI
Sullivan J, Kopp R, Stratton K, Manschreck C, Corines M, Rau-Murthy R, Hayes J, Lincon A, Ashraf A, Thomas T, Schrader K, Gallagher D, Hamilton R, Scher H, Lilja H, Scardino P, Eastham J, Offit K, Vijai J, Klein RJ., An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality., British journal of cancer, 113, (1), 2015, p166-172 , Journal Article, PUBLISHED  DOI
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, Helderman-van den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramón y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E, IMPACT Collaborators, Moss S, Eeles RA., Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study., European urology, 66, (3), 2014, p489-499 , Journal Article, PUBLISHED  DOI
  

Page 1 of 4

  

Award Date
. ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop (My registrar) 2019
American Society of Clinical Oncology Merit Award Annual Meeting 2010
American Society of Clinical Oncology Merit Award Genitourinary Symposium 2010
American Society of Clinical Oncology Merit Award Gastrointestinal Symposium 2010
American Association of Cancer Research Molecular Biology Workshop 2009
Broad Insititute Genetics of Complex Disorders Workshop 2008
Goldstein Award MSKCC Prevention and Population Research - $50,000 2008
. ASCO/AACR/FECS Methods in Clinical Cancer Research Workshop 2007
. Irish Society of Medical Oncology Scholarship to MSKCC 2006
. University College Dublin Scholarship to University of Pennsylvania 1998